Leveraging observational registries to inform comparative effectiveness research.

[1]  Joseph P. Drozda,et al.  ACC 2009 Advocacy Position Statement: Principles for comparative effectiveness research. , 2009, Journal of the American College of Cardiology.

[2]  Jeffrey L. Anderson,et al.  The American Heart Association’s Principles for Comparative Effectiveness Research: A Policy Statement From the American Heart Association , 2009, Circulation.

[3]  R. Califf,et al.  Scientific evidence underlying the ACC/AHA clinical practice guidelines. , 2009, JAMA.

[4]  B. Gersh.  Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention , 2009 .

[5]  W. Rogers,et al.  Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. , 2008, American heart journal.

[6]  Frederick A. Masoudi,et al.  Evaluating the Evidence: Is There a Rigid Hierarchy? , 2008, Circulation.

[7]  R. Hayward,et al.  Beyond the Randomized Clinical Trial the Role of Effectiveness Studies in Evaluating Cardiovascular Therapies the Achilles' Heel of Rcts Key Issues in Outcomes Research , 2022 .

[8]  Sharon-Lise T Normand,et al.  Some Old and Some New Statistical Tools for Outcomes Research , 2008, Circulation.

[9]  Harlan M Krumholz,et al.  Outcomes Research: Generating Evidence for Best Practice and Policies , 2008, Circulation.

[10]  Elijah Edwards,et al.  Enoxaparin Dosing and Associated Risk of In-Hospital Bleeding and Death in Patients With Non-ST Segment Elevation Acute Coronary Syndromes , 2008 .

[11]  Elliott S Fisher,et al.  Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. , 2007, JAMA.

[12]  J. Emberson,et al.  Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials , 2006, BMJ : British Medical Journal.

[13]  Sunil V. Rao,et al.  On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]). , 2006, The American journal of cardiology.

[14]  J. Robins,et al.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. , 2006, American journal of epidemiology.

[15]  K. Alexander,et al.  Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. , 2005, JAMA.

[16]  S. Tunis,et al.  A clinical research strategy to support shared decision making. , 2005, Health affairs.

[17]  R. Dowling,et al.  From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. , 2004, Journal of the American College of Cardiology.

[18]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[19]  Robert M Califf,et al.  Integrating quality into the cycle of therapeutic development. , 2002, Journal of the American College of Cardiology.

[20]  E. Topol,et al.  Risk of cardiovascular events associated with selective COX-2 inhibitors☆ , 2002 .

[21]  K. Alexander,et al.  Representation of elderly persons and women in published randomized trials of acute coronary syndromes. , 2001, JAMA.

[22]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials. , 2000, The New England journal of medicine.

[23]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[24]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials , 2000, American journal of ophthalmology.

[25]  J. Wennberg,et al.  Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. , 1999, JAMA.

[26]  A. Goldsobel.  TERFENADINE-KETOCONAZOLE INTERACTION: PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CONSEQUENCES , 1994, Pediatrics.

[27]  R. Califf,et al.  Percutaneous intervention, surgery, and medical therapy: a perspective from the Duke Databank for Cardiovascular Diseases. , 1994, Seminars in thoracic and cardiovascular surgery.

[28]  E. DeLong,et al.  Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes Research , 1993, Annals of Internal Medicine.

[29]  Lippincott Williams Wilkins,et al.  Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. , 1983, Circulation.